EDT vs. AKU, GEN, LMD, LXG, SQD, DXD, MBI, BUX, CRL, and NBLY
Should you be buying Spectral Medical stock or one of its competitors? The main competitors of Spectral Medical include Akumin (AKU), GeneNews (GEN), LED Medical Diagnostics (LMD), LexaGene (LXG), SQI Diagnostics (SQD), 3D Signatures (DXD), Med Biogene (MBI), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), and Neighbourly Pharmacy (NBLY). These companies are all part of the "medical" sector.
Spectral Medical vs. Its Competitors
Spectral Medical (TSE:EDT) and Akumin (TSE:AKU) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, community ranking, dividends, earnings and risk.
In the previous week, Spectral Medical had 2 more articles in the media than Akumin. MarketBeat recorded 2 mentions for Spectral Medical and 0 mentions for Akumin. Spectral Medical's average media sentiment score of 0.70 beat Akumin's score of 0.00 indicating that Spectral Medical is being referred to more favorably in the media.
Spectral Medical has higher earnings, but lower revenue than Akumin. Spectral Medical is trading at a lower price-to-earnings ratio than Akumin, indicating that it is currently the more affordable of the two stocks.
Spectral Medical has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, Akumin has a beta of 0.15, suggesting that its share price is 85% less volatile than the S&P 500.
13.0% of Spectral Medical shares are held by institutional investors. Comparatively, 30.3% of Akumin shares are held by institutional investors. 18.2% of Spectral Medical shares are held by insiders. Comparatively, 33.0% of Akumin shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Spectral Medical has a net margin of 0.00% compared to Akumin's net margin of -34.67%. Akumin's return on equity of -483.86% beat Spectral Medical's return on equity.
Spectral Medical received 106 more outperform votes than Akumin when rated by MarketBeat users. Likewise, 65.17% of users gave Spectral Medical an outperform vote while only 64.10% of users gave Akumin an outperform vote.
Summary
Spectral Medical beats Akumin on 8 of the 14 factors compared between the two stocks.
Get Spectral Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for EDT and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Spectral Medical Competitors List
Related Companies and Tools
This page (TSE:EDT) was last updated on 6/24/2025 by MarketBeat.com Staff